Cornerstone Capital Management Holdings LLC. lifted its holdings in shares of Halyard Health Inc (NYSE:HYH) by 40.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 113,764 shares of the medical instruments supplier’s stock after buying an additional 32,700 shares during the quarter. Cornerstone Capital Management Holdings LLC. owned about 0.24% of Halyard Health worth $5,122,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the stock. Dimensional Fund Advisors LP lifted its stake in Halyard Health by 5.1% in the 3rd quarter. Dimensional Fund Advisors LP now owns 3,292,483 shares of the medical instruments supplier’s stock worth $148,262,000 after purchasing an additional 159,434 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in Halyard Health by 242.8% in the 2nd quarter. Goldman Sachs Group Inc. now owns 1,864,646 shares of the medical instruments supplier’s stock worth $73,244,000 after purchasing an additional 1,320,735 shares in the last quarter. State Street Corp lifted its stake in Halyard Health by 7.5% in the 2nd quarter. State Street Corp now owns 1,702,423 shares of the medical instruments supplier’s stock worth $66,872,000 after purchasing an additional 119,154 shares in the last quarter. Paradice Investment Management LLC lifted its stake in Halyard Health by 2.1% in the 3rd quarter. Paradice Investment Management LLC now owns 1,564,813 shares of the medical instruments supplier’s stock worth $70,464,000 after purchasing an additional 31,832 shares in the last quarter. Finally, Northern Trust Corp lifted its stake in Halyard Health by 41.2% in the 2nd quarter. Northern Trust Corp now owns 1,510,297 shares of the medical instruments supplier’s stock worth $59,324,000 after purchasing an additional 440,639 shares in the last quarter. Institutional investors own 90.31% of the company’s stock.

Shares of Halyard Health Inc (NYSE HYH) opened at $47.59 on Friday. Halyard Health Inc has a 52 week low of $35.24 and a 52 week high of $50.99. The company has a quick ratio of 1.19, a current ratio of 2.13 and a debt-to-equity ratio of 0.49. The stock has a market cap of $2,196.63, a P/E ratio of 22.44, a price-to-earnings-growth ratio of 2.53 and a beta of 1.77.

Halyard Health (NYSE:HYH) last posted its quarterly earnings data on Wednesday, November 1st. The medical instruments supplier reported $0.60 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.47 by $0.13. The firm had revenue of $401.40 million for the quarter, compared to analysts’ expectations of $394.54 million. Halyard Health had a net margin of 3.52% and a return on equity of 8.65%. The business’s quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the company posted $0.48 EPS. equities analysts anticipate that Halyard Health Inc will post 2.08 earnings per share for the current fiscal year.

Several research firms have issued reports on HYH. TheStreet upgraded shares of Halyard Health from a “c+” rating to a “b” rating in a research note on Monday, December 4th. Stifel Nicolaus reiterated a “buy” rating and issued a $45.00 target price on shares of Halyard Health in a research note on Thursday, September 21st. Zacks Investment Research upgraded shares of Halyard Health from a “hold” rating to a “buy” rating and set a $53.00 target price on the stock in a research note on Wednesday, December 6th. KeyCorp reiterated a “hold” rating on shares of Halyard Health in a research note on Tuesday, October 17th. Finally, ValuEngine upgraded shares of Halyard Health from a “hold” rating to a “buy” rating in a research note on Saturday, November 4th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $46.25.

TRADEMARK VIOLATION WARNING: This story was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another domain, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The original version of this story can be read at https://www.thecerbatgem.com/2017/12/16/cornerstone-capital-management-holdings-llc-acquires-32700-shares-of-halyard-health-inc-hyh.html.

Halyard Health Company Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health Inc (NYSE:HYH).

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Stock Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related stocks with our FREE daily email newsletter.